Na SP - Search Results

1

Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.

Wang Y, Li SS, Na SP, Yu CY, Ji Y, Zhao SL, Xie RJ, Bao YS. Wang Y, et al. Among authors: na sp. Am J Med Sci. 2016 Oct;352(4):348-353. doi: 10.1016/j.amjms.2016.07.002. Epub 2016 Jul 14. Am J Med Sci. 2016. PMID: 27776715

2

Interleukin-10 genotype protects end stage renal disease patients from microinflammation and arteriosclerosis.

Wu HC, Ling H, Na SP, Xie RJ. Wu HC, et al. Among authors: na sp. Chin Med J (Engl). 2005 Sep 20;118(18):1549-51. Chin Med J (Engl). 2005. PMID: 16232332 No abstract available.

3

[The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].

Wu HC, Ling H, Na SP, Xie RJ. Wu HC, et al. Among authors: na sp. Zhonghua Yi Xue Za Zhi. 2005 Aug 3;85(29):2076-80. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16313808 Chinese.

4

Characterization of interleukin-33 and soluble ST2 in serum and their association with disease severity in patients with chronic kidney disease.

Bao YS, Na SP, Zhang P, Jia XB, Liu RC, Yu CY, Mu SH, Xie RJ. Bao YS, et al. Among authors: na sp. J Clin Immunol. 2012 Jun;32(3):587-94. doi: 10.1007/s10875-011-9622-7. Epub 2011 Dec 28. J Clin Immunol. 2012. PMID: 22203232

5

Prevalence and risk factors for chronic kidney disease in patients with coronary artery disease.

Bao YS, Na SP, Jia XB, Liu RC, Wang MA, Yu CY, Mu SH, Xie RJ. Bao YS, et al. Among authors: na sp. Curr Med Res Opin. 2012 Mar;28(3):379-84. doi: 10.1185/03007995.2012.661708. Epub 2012 Feb 16. Curr Med Res Opin. 2012. PMID: 22335251

6

Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease.

Bao YS, Ji Y, Zhao SL, Ma LL, Xie RJ, Na SP. Bao YS, et al. Among authors: na sp. Biomarkers. 2013 Aug;18(5):379-85. doi: 10.3109/1354750X.2013.790074. Epub 2013 May 7. Biomarkers. 2013. PMID: 23651343

7

Epidemiology and risk factors for chronic kidney disease in patients with ischaemic stroke.

Bao YS, Song LT, Zhong D, Song AX, Jia XB, Liu RC, Xie RJ, Na SP. Bao YS, et al. Among authors: na sp. Eur J Clin Invest. 2013 Aug;43(8):829-35. doi: 10.1111/eci.12113. Epub 2013 Jun 12. Eur J Clin Invest. 2013. PMID: 23869408

8

Characterization of soluble thrombomodulin levels in patients with stage 3-5 chronic kidney disease.

Bao YS, Jia XB, Wang D, Liu RC, Zou CB, Na SP. Bao YS, et al. Among authors: na sp. Biomarkers. 2014 Jun;19(4):275-80. doi: 10.3109/1354750X.2014.904000. Biomarkers. 2014. PMID: 24854597

9

Assessment of Renal Function and Risk Factors for Chronic Kidney Disease in Patients With Peripheral Arterial Disease.

Jia XB, Hou XH, Ma QB, Cai XW, Li YR, Mu SH, Na SP, Xie RJ, Bao YS. Jia XB, et al. Among authors: na sp. Angiology. 2017 Oct;68(9):776-781. doi: 10.1177/0003319716686876. Epub 2017 Jan 5. Angiology. 2017. PMID: 28056516

10

Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome.

Ji Y, Wang YL, Xu F, Jia XB, Mu SH, Lyu HY, Yuan XY, Na SP, Bao YS. Ji Y, et al. Among authors: na sp. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221108967. doi: 10.1177/10760296221108967. Clin Appl Thromb Hemost. 2022. PMID: 35862263 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters